Bliss GVS Pharma Ltd
BSE:506197
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bliss GVS Pharma Ltd
BSE:506197
|
IN |
|
A
|
AbraSilver Resource Corp
F:1AH
|
CA |
|
Itesoft SA
F:IE5
|
FR |
|
T
|
TCL Electronics Holdings Ltd
XBER:TC2A
|
CN |
|
IRB Infrastructure Developers Ltd
BSE:532947
|
IN |
|
ZTO Express (Cayman) Inc
F:ZTOA
|
CN |
|
OC Oerlikon Corporation AG Pfaeffikon
F:OBH
|
CH |
Wall St Price Targets
BLISSGVS Price Targets Summary
Bliss GVS Pharma Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BLISSGVS's stock price target?
Not Available
BLISSGVS does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Bliss GVS Pharma Ltd?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 6 years is 2%.
What is the Operating Income forecast for Bliss GVS Pharma Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 11 years is 1%.
What is the Net Income forecast for Bliss GVS Pharma Ltd?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 6 years is 10%.
